ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

Journal of Clinical Oncology

Volumn 19, Issue 23, 2001, Pages 4298-4304

  Shirota, Y ^a   Stoehlmacher, J ^a   Brabender, J ^a   Xiong, Y P ^a   Uetake, H ^a   Danenberg, K D ^a   Groshen, S ^a   Tsao Wei, D D ^a   Danenberg, P V ^a   Lenz, H J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN; THYMIDYLATE SYNTHASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DNA ADDUCT; DNA REPAIR; DNA REPLICATION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MALE; MESSENGER RNA SYNTHESIS; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035576102     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.23.4298     Document Type: Article

References (35)

1. Role of chemotherapy for advanced colorectal cancer: New opportunities
2. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
3. Development of treatment for advanced colorectal cancer: Infusional 5-FU and the role of new agents
4. Kinetic analysis of an in-vitro binding of radioactive cis- and trans-dichlorodiamminplatinum(II) to DNA
5. Oxaliplatin: Mechanism of action and antineoplastic activity
6. Nucleotide excision repair in Escherichia coli
7. Nucleotide excision repair: II. From yeast to mammals
8. Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD 10
9. Yeast DNA repair and recombination proteins Rad 1 and Rad 10 constitute a single-strand DNA endonuclease
10. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival
11. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival
12. p53 and thymidylate synthase gene expression in untreated stage II colon cancer: Association with recurrence, survival, and site
13. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
14. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, carcinoma sequence
15. Real time quantitative PCR
16. A novel method for real time quantitative RT-PCR
17. Maximally selected chi-square statistics
18. Maximally selected chi-square statistics for small samples
19. Asymptomatically efficient rank invariant procedures
20. Correlation between mismatch repair defects and increased replicative bypass in cisplatin resistant cell lines
21. Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cancer cell lines
22. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair
23. The role of DNA mismatch repair in platinum drug resistance
24. Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid (FA) in a compassionate-use cohort of 370 5-FU resistant advanced colorectal cancer (CRC) patients
25. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts
26. ERCC-1 and ERCC- 2 expression in malignant tissues from ovarian cancer patients
27. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy
28. Reduced expression of nucleotide excision repair genes in lung cancer: A case-control analysis
29. Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa
30. Oxaliplatin: A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies
31. dUTPase nucleotidohydrolase isoform expression in normal and neoplastic tissues: Association with survival and response to 5-fluorouracil in colorectal cancer
32. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
33. Damage recognition in nucleotide excision repair of DNA
34. Cisplatin and Adriamycin resistance are associated with MutL-alpha and mismatch repair deficiency in an ovarian tumor cell line
35. Allelic loss of chromosome 18q and prognosis in colorectal cancer